Validation of an Automated Artificial Intelligence Algorithm for the Quantification of Major OCT Parameters in Diabetic Macular Edema
暂无分享,去创建一个
E. Pilotto | E. Midena | L. Toto | C. Mariotti | M. Lupidi | M. Figus | Giuseppe Covello | Tommaso Torresin | G. Midena | L. Frizziero | Luca Danieli
[1] R. Sznitman,et al. Evaluation of an Artificial Intelligence-Based Detector of Sub- and Intraretinal Fluid on a Large Set of Optical Coherence Tomography Volumes in Age-Related Macular Degeneration and Diabetic Macular Edema , 2022, Ophthalmologica.
[2] Kai Jin,et al. OCT-Based Biomarkers are Associated with Systemic Inflammation in Patients with Treatment-Naïve Diabetic Macular Edema , 2022, Ophthalmology and Therapy.
[3] U. Schmidt-Erfurth,et al. VALIDATION OF AN AUTOMATED FLUID ALGORITHM ON REAL-WORLD DATA OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION OVER FIVE YEARS , 2022, Retina.
[4] F. Asadi,et al. Artificial intelligence in screening, diagnosis, and classification of diabetic macular edema: A systematic review. , 2022, Survey of ophthalmology.
[5] P. Tien,et al. Optical Coherence Tomography Biomarkers in Predicting Treatment Outcomes of Diabetic Macular Edema After Dexamethasone Implants , 2022, Frontiers in Medicine.
[6] S. Nicoară,et al. SD-OCT Biomarkers and the Current Status of Artificial Intelligence in Predicting Progression from Intermediate to Advanced AMD , 2022, Life.
[7] Suber S. Huang,et al. Optical Coherence Tomography Classification Systems for Diabetic Macular Edema and Their Associations With Visual Outcome and Treatment Responses – An Updated Review , 2021, Asia-Pacific journal of ophthalmology.
[8] C. Cheung,et al. OCT-based biomarkers for predicting treatment response in eyes with centre-involved diabetic macular oedema treated with anti-VEGF injections: a real-life retina clinic-based study , 2021, British Journal of Ophthalmology.
[9] R. Raman,et al. Narrative review of artificial intelligence in diabetic macular edema: Diagnosis and predicting treatment response using optical coherence tomography , 2021, Indian journal of ophthalmology.
[10] T. Wong,et al. Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis. , 2021, Ophthalmology.
[11] E. Pilotto,et al. OCT Hyperreflective Retinal Foci in Diabetic Retinopathy: A Semi-Automatic Detection Comparative Study , 2021, Frontiers in Immunology.
[12] N. Rocha,et al. Age-Friendly Health Care: A Systematic Review , 2021, Healthcare.
[13] Bianca S. Gerendas,et al. Automated quantification of macular fluid in retinal diseases and their response to anti-VEGF therapy , 2020, British Journal of Ophthalmology.
[14] V. Castro-Navarro,et al. Effect of Dexamethasone Intravitreal Implant on Visual Acuity and Foveal Photoreceptor Integrity in Macular Edema Secondary to Retinal Vascular Disease , 2020, Ophthalmologica.
[15] Bianca S. Gerendas,et al. Quantification of Fluid Resolution and Visual Acuity Gain in Patients With Diabetic Macular Edema Using Deep Learning: A Post Hoc Analysis of a Randomized Clinical Trial. , 2020, JAMA ophthalmology.
[16] R. Smolarczyk,et al. The World Health Organization (WHO) approach to healthy ageing , 2020, Maturitas.
[17] T. Jiang,et al. Supervised Machine Learning: A Brief Primer. , 2020, Behavior therapy.
[18] M. Shanmugam,et al. Validation of Deep Convolutional Neural Network-based algorithm for detection of diabetic retinopathy – Artificial intelligence versus clinician for screening , 2020, Indian journal of ophthalmology.
[19] I. Pinilla,et al. Interpretation of OCT and OCTA images from a histological approach: Clinical and experimental implications , 2020, Progress in Retinal and Eye Research.
[20] Jeany Q. Li,et al. Prevalence, incidence and future projection of diabetic eye disease in Europe: a systematic review and meta-analysis , 2019, European Journal of Epidemiology.
[21] Wynne Hsu,et al. Artificial Intelligence Screening for Diabetic Retinopathy: the Real-World Emerging Application , 2019, Current Diabetes Reports.
[22] I. Rudan,et al. Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors , 2019, Journal of global health.
[23] Amir Sadeghipour,et al. Artificial intelligence in retina , 2018, Progress in Retinal and Eye Research.
[24] E. Pilotto,et al. Hyperreflective Intraretinal Foci as an OCT Biomarker of Retinal Inflammation in Diabetic Macular Edema. , 2018, Investigative ophthalmology & visual science.
[25] Bianca S. Gerendas,et al. Fully Automated Detection and Quantification of Macular Fluid in OCT Using Deep Learning. , 2017, Ophthalmology.
[26] Min Zhao,et al. Mechanisms of macular edema: Beyond the surface , 2017, Progress in Retinal and Eye Research.
[27] A. Loewenstein,et al. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant. , 2017, Ophthalmology.
[28] S. Vujosevic,et al. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti‐VEGF treatment in diabetic macular oedema , 2017, Acta ophthalmologica.
[29] S. Vujosevic,et al. HYPERREFLECTIVE RETINAL SPOTS IN NORMAL AND DIABETIC EYES: B-Scan and En Face Spectral Domain Optical Coherence Tomography Evaluation , 2017, Retina.
[30] Terry K Koo,et al. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. , 2016, Journal Chiropractic Medicine.
[31] E. Midena,et al. Multimodal retinal imaging of diabetic macular edema: toward new paradigms of pathophysiology , 2016, Graefe's Archive for Clinical and Experimental Ophthalmology.
[32] Arup Das,et al. Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets. , 2015, Ophthalmology.
[33] N. Bressler,et al. Comparison of time- and spectral-domain optical coherence tomography in management of diabetic macular edema. , 2014, Investigative ophthalmology & visual science.
[34] M. McHugh. Interrater reliability: the kappa statistic , 2012, Biochemia medica.
[35] E. Pilotto,et al. Emerging Insights into Pathogenesis. , 2017, Developments in ophthalmology.